Updates
Added by St.2020, c.260, § 2, effective January 1, 2021
Section 17R
The commission shall provide to any active or retired employee of the commonwealth who is insured under the group insurance commission coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobulin therapy.
Contact
Online
Address
9th Floor
Boston, MA 02108
Last updated: | January 1, 2021 |
---|